Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.740
+0.160 (10.13%)
At close: Oct 9, 2025, 4:00 PM EDT
1.830
+0.090 (5.17%)
Pre-market: Oct 10, 2025, 5:23 AM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $123.73 million as of October 10, 2025. Its market cap has increased by 52.94% in one year.
Market Cap
123.73M
Enterprise Value
99.48M
1-Year Change
52.94%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has decreased from $301.40M to $123.73M, a decrease of -58.95%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 123.70M | 86.58% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |